Our Follow-up Letter to FDA Commissioner Margaret HamburgPosted: April 30th, 2013 | Filed under: Incident Reports | Tags: asthma, autism, cancer, Center for Food Safety and Applied Nutrition, Commissioner, diabetes, FDA, gmo, GMO Labeling, just label it, letter, Margaret Hamburg, Meeting, Response, Safety Studies, stone soup |
Margaret A. Hamburg, M.D.
10903 New Hampshire Avenue
Silver Spring, MD 20993
April 29, 2013
Dear Commissioner Hamburg,
We sincerely appreciated the response from your secretary on April 4, concerning your inability to attend our demonstration outside the Center for Food Safety and Applied Nutrition that took place on Monday, April 8. The demonstration was successful and generated numerous newspaper articles across the country.
We write today to request a meeting with you concerning the labeling of genetically engineered foods in America. We are aware that representatives from the FDA have attended similar meetings with representatives from the chemical and processed food industries, and we deserve the opportunity to meet and discuss our concerns. We are willing to accommodate your busy schedule and can meet on the date and time of your choosing in May, June, or July. Upon confirmation from your office, we intend to invite business leaders in the organic food industry who share our concerns related to labeling of genetically engineered foods.
As you know, last year there were over one million signatures submitted to your agency asking you to require mandatory labels for foods produced using modern genetic engineering techniques. However, we still have not received a thorough reply from the FDA regarding this petition. We have reviewed the statements on the FDA website, and have concluded that instituting mandatory labels for genetically engineered foods is currently within your power and that such implementing such a policy does not require Congressional action.
Your failure to allay the concerns of American consumers and respond to the petition has resulted in growing distrust of your agency. We interpret the FDA’s resolve to ignore the people’s overwhelming support of mandatory GMO labeling as demonstrative of your true priority: protecting corporate interests, rather than protecting consumers’ safety and our fundamental right to transparency in food labeling. If the FDA is to regain the trust of American consumers you must demonstrate real action and commitment to introducing GMO labeling policy. Our proposed meeting is the crucial first step in beginning that process.
Consumers want the FDA to reject the purported authority of arbitrary biotechnology corporations as providers of safety studies. We demand independent tests conducted by the FDA or respected researchers at universities. Moreover, consumers are concerned that the existing body of safety studies are woefully incomplete and do not reflect the data recorded over the entire lifespan of animals fed genetically engineered foods.
The biotechnology industry says that there have been over 3 trillion meals served using genetically engineered ingredients without any health issues. We believe this statement is misleading; it is impossible to trace any health effects due to the consumption of genetically engineered foods when there are no mandatory labels on genetically engineered foods. Conversely, since genetically engineered foods entered the American food supply in the late 1990s, there has been a noticeable increase in diabetes, asthma, autism, cancer, and stomach maladies in America. Some concerned consumers believe this unfortunate increase is the direct result of consuming genetically engineered foods. This anecdotal evidence is not based on science. However, unless consumers are given the opportunity to choose between foods that contain genetically engineered ingredients and those that don’t, the anecdotal evidence will continue to yield further speculation on the dangers of consuming genetically engineered foods.
We look forward to hearing from you.
GMO Policy Analyst